Toxoplasmosis in Pregnancy: Diagnosis, Risk Factors, and Management

Authors

  • Mohamed Abdelgadir Shaaeldin Department of Obstetrics and Gynecology, University of Bahri, Khartoum ,Sudan
  • Sumeya A. Khieri Department of Obstetrics and Gynecology, University of Bahri, Khartoum ,Sudan
  • Khalid Nasralla Obstetrics and Gynecology, College of Medicine, Qassim University, Buriadah, Saudi Arabia
  • Zaheera Saadia
  • Mohamed Alkhatim Alsammani Department of Obstetrics and Gynecology, University of Bahri, Khartoum ,Sudan Obstetrics and Gynecology, College of Medicine, Qassim University, Buriadah, Saudi Arabia Department of Obstetrics and Gynecology, Qassim University, College of Medicine, Buriadah, KSA, P.OBox:665. Buraidah, 51452, KSA, cell phone +966568525808

Keywords:

Toxoplasmosis, pregnancy, diagnosis, prevention, mass screening, treatment.

Abstract

Toxoplasma gondiiis an opportunistic parasitic protozoan infection. Toxoplasmosis is the most common food-borne infection throughout the world. In pregnancy, fetal complications range from abortion, physically-disabled children to fetal demise. This review examined risk factors diagnosis and treatment of Toxoplasma gondii during pregnancy pregnant.Pregnant women contract the infection through contaminated food, unpasteurized milk and proximity with infected animals most commonly cats. Recent evident have demonstrated the benefit of screening and treatment for toxoplasmosis duringperiod of pregnancyby decreasing vertical transmission of the Toxoplasma gondiiparasite to the growing fetus. There are several ways for pregnant women to protect themselves from contracting the disease during pregnancy. In this review, we discussed diagnosis, prevention, and management of toxoplasmosis during pregnancy.

References

. Tenter, A.M., A.R. Heckeroth, and L.M. Weiss.Toxoplasmagondii: from animals to humans. Int J Parasitol. 2000; 30(12-13):1217-58.

. Hill, D. and J.P. Dubey.Toxoplasmagondii: transmission, diagnosis and prevention. ClinMicrobiol Infect. 2002; 8(10):634-40.

. Montoya, J.G. and O. Liesenfeld.Toxoplasmosis. Lancet. 2004; 363(9425):1965-76.

. Alsammani, M.A.Sero-epidemiology and risk factors for Toxoplasma gondii among pregnant women in Arab and African countries. J Parasit Dis. 2016; 40(3):569-79.

. Alsammani, M.A., S.R. Ahmed, M.A. Alsheeha, Z. Saadia, and S.A. Khairi.Co-infection with Toxoplasma gondii and Clostridium perfringens in a postpartum woman with uterine gas gangrene: a case report. J ObstetGynaecol Res. 2012; 38(7):1024-7.

. Jones, J.L., A. Lopez, M. Wilson, J. Schulkin, and R. Gibbs.Congenital toxoplasmosis: a review. ObstetGynecolSurv. 2001; 56(5):296-305.

. Foulon, W., J.M. Pinon, B. Stray-Pedersen, A. Pollak, M. Lappalainen, A. Decoster, et al.Prenatal diagnosis of congenital toxoplasmosis: a multicenter evaluation of different diagnostic parameters. Am J Obstet Gynecol. 1999; 181(4):843-7.

. Jones, J., A. Lopez, and M. Wilson.Congenital toxoplasmosis. Am Fam Physician. 2003; 67(10):2131-8.

. Brown, E.D., J.K. Chau, S. Atashband, B.D. Westerberg, and F.K. Kozak.A systematic review of neonatal toxoplasmosis exposure and sensorineural hearing loss. Int J PediatrOtorhinolaryngol. 2009; 73(5):707-11.

. Bilal JA, Alsammani MA, Ahmed MI. Acute Toxoplasma gondii infection in children with reactive hyperplasia of the cervical lymph nodes. Saudi Med J. 2014 Jul;35(7):699-703

. Wilson, C.B., J.S. Remington, S. Stagno, and D.W. Reynolds.Development of adverse sequelae in children born with subclinical congenital Toxoplasma infection. Pediatrics. 1980; 66(5):767-74.

. Stricker, R., R. Sitavanc, N. Liassine, and F. de Marval.Toxoplasmosis during pregnancy and infancy. Swiss Med Wkly. 2009; 139(43-44):643-4; author reply 43-4.

. Remington, J.S., R. McLeod, P. Thulliez, and G. Desmonts, Toxoplasmosis, in Infectious Diseases of the Fetus and Newborn Infant, J.S. Remington and J.O. Klein, Editors. 2001, The WB Saunders Co: Philadelphia, PA. p. 205-346.

. Pereira, K.S., R.M. Franco, and D.A. Leal.Transmission of toxoplasmosis (Toxoplasma gondii) by foods. Adv Food Nutr Res. 2010; 601-19.

. Liesenfeld, O., C. Press, J.G. Montoya, R. Gill, J.L. Isaac-Renton, K. Hedman, et al.False-positive results in immunoglobulin M (IgM) toxoplasma antibody tests and importance of confirmatory testing: the PlateliaToxoIgM test. J ClinMicrobiol. 1997; 35(1):174-8.

. Jones, C.A.Maternal transmission of infectious pathogens in breast milk. J Paediatr Child Health. 2001; 37(6):576-82.

. Montoya, J.G.Laboratory diagnosis of Toxoplasma gondii infection and toxoplasmosis. J Infect Dis. 2002; 185Suppl 1S73-82.

. Howe, D.K. and L.D. Sibley.Toxoplasmagondii comprises three clonal lineages: correlation of parasite genotype with human disease. J Infect Dis. 1995; 172(6):1561-6.

. Elbez-Rubinstein, A., D. Ajzenberg, M.L. Darde, R. Cohen, A. Dumetre, H. Yera, etal.Congenital toxoplasmosis and reinfection during pregnancy: case report, strain characterization, experimental model of reinfection, and review. J Infect Dis. 2009; 199(2):280-5.

. Delhaes, L., D. Ajzenberg, B. Sicot, P. Bourgeot, M.L. Darde, E. Dei-Cas, etal.Severe congenital toxoplasmosis due to a Toxoplasma gondii strain with an atypical genotype: case report and review. PrenatDiagn. 2010; 30(9):902-5.

. Tammam, A. E., M. A. Haridy, A. H. Abdellah, S. R. Ahmed, H. M. Fayed & M. A. Alsammani (2013) Seroepidemiology of Toxoplasma gondii infection in women with first trimester spontaneous miscarriage in qena governorate, egypt. J ClinDiagn Res, 7, 2870-3.

. Mwambe, B., S.E. Mshana, B.R. Kidenya, A.N. Massinde, H.D. Mazigo, D. Michael, etal.Sero-prevalence and factors associated with Toxoplasma gondii infection among pregnant women attending antenatal care in Mwanza, Tanzania. Parasit Vectors. 2013; 6222.

. Walle, F., N. Kebede, A. Tsegaye, and T. Kassa.Seroprevalence and risk factors for Toxoplasmosis in HIV infected and non-infected individuals in Bahir Dar, Northwest Ethiopia. Parasit Vectors. 2013; 6(1):15.

. Minbaeva, G., A. Schweiger, A. Bodosheva, O. Kuttubaev, A.B. Hehl, I. Tanner, et al.Toxoplasmagondii infection in Kyrgyzstan: seroprevalence, risk factor analysis, and estimate of congenital and AIDS-related toxoplasmosis. PLoSNegl Trop Dis. 2013; 7(2):e2043.

. Jones, J.L., V. Dargelas, J. Roberts, C. Press, J.S. Remington, and J.G. Montoya.Risk factors for Toxoplasma gondii infection in the United States. Clin Infect Dis. 2009; 49(6):878-84.

. Peyron, F., M. Wallon, C. Liou, and P. Garner.Treatments for toxoplasmosis in pregnancy. Cochrane Database Syst Rev. 2000; (2):CD001684.

. di Carlo, P., A. Romano, A. Casuccio, S. Cillino, M.G. Schimmenti, G. Mancuso, et al.Investigation and management of Toxoplasma gondii infection in pregnancy and infancy: a prospective study. ActaPharmacol Sin. 2011; 32(8):1063-70.

. Vimercati, A., P. Greco, A. D'Apolito, M.C. Angelici, A. Possenti, S. Carbonara, et al.[Risk assessment of vertical transmission of Toxoplasma infections]. Acta Biomed AteneoParmense. 2000; 71Suppl 1537-40.

. Montoya, J.G. and J.S. Remington.Management of Toxoplasma gondii infection during pregnancy. Clin Infect Dis. 2008; 47(4):554-66.

. Serranti, D., D. Buonsenso, and P. Valentini.[Congenital toxoplasmosis treatment]. Eur Rev Med Pharmacol Sci. 2011; 15(2):193-8.

Downloads

Additional Files

Published

2018-03-25

How to Cite

Shaaeldin, M. A., A. Khieri, S., Nasralla, K., Saadia, Z., & Alsammani, M. A. (2018). Toxoplasmosis in Pregnancy: Diagnosis, Risk Factors, and Management. International Journal of Sciences: Basic and Applied Research (IJSBAR), 37(3), 205–211. Retrieved from https://www.gssrr.org/index.php/JournalOfBasicAndApplied/article/view/8812

Issue

Section

Articles